Skip to content
DataLookout
Menu

NCT07124702

Cessation of Dual Use of Cigarettes and E-cigarettes During Pregnancy

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved 12 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Sep 30, 2026 to Sep 30, 2027
    • Eligibility criteria expanded, about 10 words
    • Study completion pushed from Mar 31, 2027 to Mar 31, 2028
    • Secondary endpoints: details revised at 3 of 3 entries
  2. Notable Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Aug 31, 2026 to Sep 30, 2026
    • Study completion date: Feb 28, 2027 to Mar 31, 2027
    • Start date changed from estimate of Sep 1, 2025 to Oct 1, 2025
    • Site details revised
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Nicotine abstinence
Timeframe: 8 weeks after randomization, at the end of pregnancy

Secondary (3)

The time needed to achieve nicotine abstinence
The mother's gestational weight gain
The infant's birth-weight-forgestational- age z score

Arms and interventions

Simultaneous cessation interventionExperimental

This simultaneous cessation intervention group will target CCs and ECs at the same time. Participants in this group will receive a multi-component cessation intervention, including behavior counseling, biomarker feedback via monitoring changes in levels of exposure to nicotine (urine cotinine) and CC smoke (breath carbon monoxide), and contingent financial incentives for biochemically verified abstinence.

Stepwise cessation interventionExperimental

This stepwise cessation intervention group will first target CCs and then target ECs after quitting CCs. Participants in this group will receive a multi-component cessation intervention, including behavior counseling, biomarker feedback via monitoring changes in levels of exposure to nicotine (urine cotinine) and CC smoke (breath carbon monoxide), and contingent financial incentives for biochemically verified abstinence.

Control groupActive comparator

Participants assigned to the control group will receive behavior counseling only. They will complete the same number of study visits as their counterparts in the intervention groups.

Behavioral: Simultaneous cessation intervention, Stepwise cessation intervention, Behavior counseling only

Sites

1 site in 1 country

  • State University of New York at BuffaloBuffalo, New York, United States